MedDataX Logo

Posterior Capsule Opacification (PCO) Evaluation of the AcrySof SN60AT Lens vs. SN60WF Lens

NCT ID: NCT00762021

Last Updated: 2010-12-22

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

104 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess posterior capsule opacification (PCO) in patients implanted with either the AcrySof SN60AT lens or the AcrySof SN60WF lens.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SN60AT

Implantation with the AcrySof Intraocular Lens Model SN60AT

Group Type EXPERIMENTAL

SN60AT

Intervention Type DEVICE

Implantation with the AcrySof Intraocular Lens Model SN60AT following cataract removal.

SN60WF

Implantation with the AcrySof Intraocular Lens Model SN60WF

Group Type ACTIVE_COMPARATOR

SN60WF

Intervention Type DEVICE

Implantation with the AcrySof Intraocular Lens Model SN60WF following cataract removal.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SN60AT

Implantation with the AcrySof Intraocular Lens Model SN60AT following cataract removal.

Intervention Type DEVICE

SN60WF

Implantation with the AcrySof Intraocular Lens Model SN60WF following cataract removal.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with bilateral senile cataracts
* Age \> 50 years
* Fit for hospital follow ups
* Pupils dilating \> 6mm preoperatively
* Eyes expected to see 6/12 or better postoperatively

Exclusion Criteria

* Diabetes
* On treatment for glaucoma
* Other ocular pathology
* Previous ocular surgery
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Associate Director, Surgical IOL, Clinical Science

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Contact Alcon Call Center for Trial Locations

Fort Worth, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P-06-26

Identifier Type: -

Identifier Source: org_study_id